HAP Trading’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

HAP Trading’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-12,535	Closed	-$1.12M	–	884
2024 Q1	$1.19M	Buy	+12,535	New	+$1.16M	0.14%	112
2023 Q2	–	Sell	-162,223	Closed	-$13.6M	–	1403
2023 Q1	$12.4M	Buy	162,223 +139,043	+600%	+$11.5M	1.93%	6
2022 Q4	$1.92M	Sell	23,180 -19,097	-45%	-$1.55M	0.2%	128
2022 Q3	$3.35M	Sell	42,277 -33,853	-44%	-$2.85M	0.22%	100
2022 Q2	$5.65M	Buy	76,130 +33,965	+81%	+$2.55M	0.28%	67
2022 Q1	$3.79M	Sell	42,165 -501,665	-92%	-$46.3M	0.16%	111
2021 Q4	$60.9M	Buy	+543,830	New	+$65.6M	1.66%	4
2015 Q4	–	Sell	-35,963	Closed	-$2.45M	–	1136
2015 Q3	$2.24M	Buy	+35,963	New	+$2.83M	0.12%	172

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

HAP Trading's XBI Position: Q2 2024 in Review

HAP Trading sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2024, closing a stake of 12,535 shares — an estimated $1.12M sold.

HAP Trading first reported a position in XBI in Q3 2015 and held it in 8 quarters. The position peaked at $60.9M in Q4 2021. 761 funds tracked by Wall St. Rank hold XBI as of Q2 2024.

HAP Trading reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2024 after selling out during the quarter.
HAP Trading sold 12,535 State Street SPDR S&P Biotech ETF shares in Q2 2024, an estimated $1.12M.
HAP Trading first reported a position in State Street SPDR S&P Biotech ETF in Q3 2015 and held it in 8 quarters.
HAP Trading's State Street SPDR S&P Biotech ETF position peaked at $60.9M in Q4 2021.
761 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2024.

Based on HAP Trading's 13F filing for Q2 2024, filed 14 Aug 2024.